UK Biobank has announced that a consortium of ten biopharma companies will conduct a study to analyse circulating concentrations of almost 1,500 plasma proteins in around 53,000 of its participants.
Identifying genetic variants that control disease-causing blood proteins isn’t an easy task. A team led by scientists at the University of Cambridge and Merck & Co. has created a “genetic atlas” of such genetic links that could help reveal biomarkers for